Skip to Main Content

A preview of the burning biotech and health tech questions at JPM 2022

A rundown of what to look for at this year's J.P. Morgan Healthcare Conference.

FDA authorizes Pfizer pill to treat Covid-19 in patients as young as 12

The Food and Drug Administration on Wednesday authorized Paxlovid, a pill developed and made by Pfizer, as a treatment for Covid-19, a significant step in the battle against the SARS-CoV-2 virus.

Claims of vaccine hesitancy in African countries are at odds with the reality on the ground

At best, claims of widespread vaccine hesitancy across African nations are uninformed speculation. At worst, they are attempts to distract people from the injustice of unequal access to Covid-19 vaccines by blaming Africans.

FDA expands authorization for Pfizer’s Covid-19 booster to cover 16- and 17-year-olds

The FDA has expanded the emergency use authorization for Pfizer and BioNTech’s Covid-19 booster shot to cover 16- and 17-year- olds, making it the only booster available in the U.S. for teens in this age group.

Pharmalittle: Vaccine makers scramble to assess the Omicron Covid strain; Pfizer to step up Covid pill production

Vaccine makers will spend several weeks assessing the danger and potential impact of the new Omicron variant of Covid-19, but they're already developing ways to combat it.

Pfizer’s Covid-19 vaccine was 100% effective in kids in longer-term study

Pfizer and BioNTech announced that their Covid-19 vaccine was 100% efficacious in preventing infections in 12 to 15 year olds in a longer-term study.

‘Late is better than never’: Biden plan to boost U.S. production of Covid vaccines gets mixed reviews

“Late is definitely better than never,” said Jayasree Iyer of the Access to Medicines Foundation. “But so much more may have been accomplished if such steps were taken sooner.”

Pfizer to file for emergency authorization Tuesday for its Covid-19 pill

Pfizer CEO Albert Bourla said at the #STATSummit that the company plans to ask tthe FDA on Tuesday to authorize emergency use of its antiviral pill to combat Covid-19.

‘A work in progress’: BioNTech’s CEO wants to widen Covid-19 vaccine access on his own terms

"We want to ensure that mRNA vaccines can be produced in Africa, for Africa, at the same quality as everywhere else," said BioNTech CEO Ugur Sahin.

Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs

Who invented Moderna's Covid-19 vaccine? Can psychedelic medicines be mainstream? And who's going to run the FDA? All that and more on the latest episode of "The Readout LOUD." Listen now:

Pharmalittle: Democrats reach a deal on drug pricing; CDC OKs Pfizer Covid shot for kids ages 5 to 11

Congressional Democrats announced they had agreed to a broad plan to overhaul the way America pays for prescription medicines.

FDA authorizes Pfizer Covid-19 vaccine for children aged 5 to 11

The FDA granted emergency use authorization to the Covid-19 vaccine developed by Pfizer and its partner BioNTech for children ages 5 to 11.

STAT announces third annual 2021 STAT Summit

2021 STAT Summit will feature NIAID Director Dr. Anthony Fauci and Pfizer CEO Albert Bourla BOSTON, MA - Today, STAT, the nation’s must-read health, science, and medicine publication, announced its 2021 STAT Summit. The event will be hybrid from November 16-18, 2021, with programming taking place from 1:00 - 4:30 p.m. ET each day. The…

Pharmalittle: Pfizer CEO rallies employees to fight drug-price negotiations; Glaxo head pressured by another activist fund

GlaxoSmithKline CEO Emma Walmsley has come under pressure from a second activist hedge fund, which has taken a stake worth about $14 million to push for change at the top.

The debate over Covid-19 vaccine boosters, what to call them, and whether they’re needed

U.S. health officials want you to get another shot of Covid-19 vaccine. But some experts in the vaccine world don’t think we should be using the B word to describe that extra jab.

Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist

At the Pearl River, N.Y., research center where the Pfizer vaccine was created, a team of “variant hunters” race to track changes in the fast-mutating SARS-CoV-2.

FDA grants full approval to Covid-19 vaccine developed by Pfizer, BioNTech

Health experts hope the full approval of Pfizer's Covid-19 vaccine will persuade some people who remain hesitant about it to get the shot.

Pharmalittle: Pfizer says ‘trust us’ when it comes to a Covid-19 booster; FDA OKs extra dose of the mRNA shots for some people

Pfizer has not yet delivered conclusive proof and lacks late-stage clinical trial results to confirm a booster shot will work against Covid-19 variants.

Sanofi pays $3 billion to purchase Translate, raising stakes around mRNA technology

In buying Translate Bio, Sanofi will own the rest of the company's mRNA pipeline, which includes treatments for rare diseases of the lung, all of which are in the earliest stages of development.

Pfizer looks to widen access to Covid-19 vaccine in Africa, but advocates say it doesn’t go far enough

“It is more about keeping control than about sharing intellectual property and technology,” said Ellen ‘t Hoen, a global health researcher.

Pharma CEOs, lobbyists showered Democrat with cash after his attempt to torpedo Pelosi’s drug pricing bill

Large drug makers and lobbyists have funneled $67,400 to Rep. Scott Peters after his attempt to torpedo Nancy Pelosi’s drug pricing bill.

2021 STAT Summit

nov 16-18hybrid event#statsummit View Highlights About Charting a course for medicine's future Leading figures in science and medicine joined us at the 2021 STAT Summit. Corporate executives, top scientists, patient advocates, and government officials had spirited discussions with each other, and with STAT’s award-winning reporters. They answered your questions and dove deep into the hottest…

When and how will we know if we need Covid-19 booster shots?

STAT reporters unpack your biggest questions about Covid-19 boosters, including when we’ll actually know if they’re needed, what we know about Pfizer’s efficacy data, and what the need for boosters might mean for vaccine maker balance sheets.

Boxed in: How a single Pfizer decision complicated the Covid vaccine rollout while boosting profits

Pfizer says its decision was intended to speed vaccine delivery, but it meant the Covid shots were sent mostly to densely populated areas and not to pharmacies and primary care doctors — cornerstones of fast and effective vaccine distribution.

FDA authorizes Pfizer’s Covid-19 vaccine for use in adolescents

The FDA has agreed to let adolescents between the ages of 12 and 15 be vaccinated with the Pfizer and BioNTech Covid-19 vaccine, making it the first vaccine to be available for use in that age group.

Pharmalittle: Biden supports WTO proposal on Covid-19 vaccine IP; Biogen Alzheimer’s drug is cost-effective at $2,500

The controversial Biogen Alzheimer’s treatment would only be cost-effective if it is priced between $2,500 and $8,300 a year due to “insufficient” evidence that the drug works, according to a preliminary analysis.

Pfizer and BioNTech to provide Covid-19 vaccine to Olympic, Paralympic delegations

Pfizer and its partner BioNTech announced that they would provide Covid-19 vaccine to all Olympic and Paralympic delegations headed to the Summer Games in Tokyo.

U.S. government has invested $6 billion in Moderna’s Covid-19 vaccine

The federal government has now invested about $6 billion in the Covid-19 vaccine from Moderna, the Cambridge, Mass., biotech that few outside the scientific and investment worlds had heard of a couple of years ago.